Bortezomib Related Compounds & Impurities

Bortezomib is a first-in-class reversible 26S proteasome inhibitor that disrupts protein homeostasis in malignant plasma cells, used for multiple myeloma and mantle cell lymphoma.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Bortezomib reference standards, pharmacopeial and non-pharmacopeial Bortezomib impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Bortezomib-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Bortezomib
Bortezomib Form II
Bortezomib R,R-Isomer Impurity
Bortezomib Impurity G
(S,R)-Bortezomib Hydroxyisopentyl Amide Analog
Bortezomib Impurity 36
Bortezomib Impurity A
Bortezomib Pinanediol Ester
Bortezomib Hydroxy Impurity (1R,2S)-Isomer
Bortezomib Impurity (S,S-Isomer)
Bortezomib (1S,2R)-Isomer
Bortezomib Impurity C
Bortezomib Impurity F
Bortezomib Impurity H
Bortezomib Impurity 42
(S)-3-Cyclopropyl-3-(3-((2-(5,5-dimethylcyclopent-1-en-1-yl)-2`-fluoro-5`-methoxy-[1,1`-biphenyl]-4-yl)methoxy)phenyl)propanoic acid
Bortezomib Amino R Isomer trifluoroacetate
Bortezomib Impurity 2 (Mixture of (1S,2R)-Isomer and (1R,2R)-Isomer)
Bortezomib Impurity 33
Bortezomib N-formyl analog
Hydroxybortezomib
Bortezomib R-Hydroperoxide
Bortezomib S-Hydroperoxide
Bortezomib D-phenylalanyl analog
(S)-Hydroxy Des(boric Acid) Bortezomib
N-(pyrazine-2-yl-carbonyl)-L-phenylalanine
Bortezomib Impurity 7
(S)-N-(1-Formamido-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
Bortezomib USP Imp F
Bortezomib Impurity 9
Bortezomib Impurity 28
Bortezobib Diastereomers S,S
Bortezomib Impurity 2 (RR-Isomer)
Bortezomib Related Compound P
Desisobutyl-n-butyl Bortezomib
Bortezomib Impurity (R,R-Isomer)
3-phenyl-2-(pyrazine-2-carboxamido)propanoic acid
Bortezomib Impurity 6
Bortezomib Desphenylalanyl Analog
(S,R) Bortezomib
Bortezomib Impurity 69
Bortezomib Hydroxyketone Analog
N-(2-Pyrazinylcarbonyl)-D-phenylalanine
Bortezomib Impurity 74
Bortezomib Impurity 73
Bortezomib Impurity 4
Bortezomib Impurity 10
Bortezomib Impurity 11
Bortezomib Impurity 41
Bortezomib Impurity 53
Bortezomib Impurity 1
Bortezomib Intermediate(S,R)
Bortezomib Impurity C (Mixture of Isomers)
Bortezomib R,R and S,S Diastereomer impurities
Bortezomib Impurity 3
Isoamylamide Impurity
pyrazine-2-carboxylic acid [1-(1-hydroxy-3-methyl-butylcarbamoyl)-2-phenyl-ethyl]amide
Bortezomib Trimetric Form
Bortezomib Impurity 31
Bortezomib D-Mannitol Ester
Bortezomib impurity U
Bortezomib Impurity 81
Bortezomib Impurity B
Bortezomib Hydroxy Impurity (1S,2R)-Isomer
Bortezomib Impurity 12
Bortezomib Impurity 13
Bortezomib Impurity 5
N-Nitroso Bortezomib Impurity 1
Bortezomib Impurity 14

Isotope Labelled Compounds

Bortezomib-D8
Bortezomib-D5